WASHINGTON, Nov. 12 -- Avenue Therapeutics Inc., Miami, Florida, a specialty pharmaceutical company founded by Fortress Biotech Inc., Bay Harbor Islands, Florida, announced that its majority-owned subsidiary, Baergic Bio Inc., New York, has been acquired by Axsome Therapeutics Inc., New York. The transaction transfers the global rights to BAER-101, which will now be known as AXS-17 under Axsome's development. The acquiring company intends to evaluate the compound as a potential treatment fo . . .

Click here for more information about our products